Charles Schwab’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $126K | Sell |
403,514
-229,015
| -36% | -$71.2K | ﹤0.01% | 3404 |
|
|
2025
Q1 | $309K | Sell |
632,529
-68,307
| -10% | -$33.4K | ﹤0.01% | 3203 |
|
|
2024
Q4 | $600K | Sell |
700,836
-34,381
| -5% | -$29.4K | ﹤0.01% | 3084 |
|
|
2024
Q3 | $6.25M | Buy |
735,217
+457,940
| +165% | +$3.89M | ﹤0.01% | 2257 |
|
|
2024
Q2 | $1.29M | Buy |
277,277
+252,773
| +1,032% | +$1.18M | ﹤0.01% | 2838 |
|
|
2024
Q1 | $167K | Hold |
24,504
| – | – | ﹤0.01% | 3259 |
|
|
2023
Q4 | $82.1K | Hold |
24,504
| – | – | ﹤0.01% | 3362 |
|
|
2023
Q3 | $61K | Hold |
24,504
| – | – | ﹤0.01% | 3389 |
|
|
2023
Q2 | $31.4K | Buy |
+24,504
| New | +$31.4K | ﹤0.01% | 3499 |
|
|
2022
Q2 | – | Sell |
-38,968
| Closed | -$83K | – | 3544 |
|
|
2022
Q1 | $83K | Sell |
38,968
-6,111
| -14% | -$13K | ﹤0.01% | 3446 |
|
|
2021
Q4 | $404K | Buy |
45,079
+1,743
| +4% | +$15.6K | ﹤0.01% | 3216 |
|
|
2021
Q3 | $720K | Sell |
43,336
-317
| -0.7% | -$5.27K | ﹤0.01% | 3005 |
|
|
2021
Q2 | $908K | Buy |
43,653
+4,507
| +12% | +$93.7K | ﹤0.01% | 2968 |
|
|
2021
Q1 | $735K | Buy |
39,146
+5,042
| +15% | +$94.7K | ﹤0.01% | 2947 |
|
|
2020
Q4 | $751K | Sell |
34,104
-91
| -0.3% | -$2K | ﹤0.01% | 2861 |
|
|
2020
Q3 | $710K | Buy |
34,195
+2,180
| +7% | +$45.3K | ﹤0.01% | 2772 |
|
|
2020
Q2 | $1.16M | Buy |
32,015
+11,529
| +56% | +$417K | ﹤0.01% | 2581 |
|
|
2020
Q1 | $670K | Buy |
20,486
+6,845
| +50% | +$224K | ﹤0.01% | 2606 |
|
|
2019
Q4 | $373K | Buy |
+13,641
| New | +$373K | ﹤0.01% | 2926 |
|